MT-II Spray – Research Peptide
MT-II Spray is a cyclic peptide analog of α-MSH specifically designed for advanced melanocortin receptor research. It primarily targets MC1R, MC3R, and MC4R receptors and is predominantly studied in vitro, offering a precise tool for scientific exploration.
- Cyclic peptide analog of α-MSH for receptor specificity
- Effective interaction with MC1R, MC3R, and MC4R
- Designed for in vitro melanocortin receptor studies
- High receptor affinity and selectivity for targeted research
- Delivered in a convenient spray form for controlled application
Compared to traditional linear peptides, MT-II Spray showcases enhanced stability and receptor binding due to its cyclic structure, which improves resistance to enzymatic degradation. This advancement places it ahead of many previous analogs by providing more consistent and replicable results in melanocortin receptor assays. Its focus on MC1R, MC3R, and MC4R allows researchers to study critical pathways in pigmentation, energy homeostasis, and metabolic regulation with greater specificity.
Key Technical Advantages: Technology and Performance
MT-II Spray integrates cutting-edge peptide design to enhance receptor affinity and stability, which are crucial for reliable in vitro research outcomes. The cyclic formation improves half-life and biological activity, while the spray delivery system ensures ease of use and precise dosing. These technological improvements support more effective melanocortin receptor studies, enabling researchers to explore receptor mechanisms with improved accuracy and efficiency.